INSUBCONTINENT EXCLUSIVE:
NEW DELHI: The Nifty Pharma index was trading 0.44 per cent up at 9,673 around 10:50 am on Friday, backed by gains in shares of Sun
Pharmaceutical Industries (up 1.37 per cent), Cipla (up 1.19 per cent) and Divi's Laboratories (up 1.18 per cent).
Shares of Sun Pharma
spurted after media reported that the USFDA has reclassified its Halol unit as "No Action Initiated"
The scrip rallied over 2 per cent to Rs 616.65 in early trade
Reddy's Laboratories (up 0.99 per cent), Glenmark Pharmaceuticals (up 0.41 per cent) and Cadila Healthcare (up 0.29 per cent) too were
trading with gains.
However, Biocon (down 1.66 per cent), Piramal Enterprises (down 0.94 per cent), Aurobindo Pharma (down 0.46 per cent)
and Lupin (down 0.39 per cent) were trading in the negative territory at that time
Equity market benchmarks Sensex and Nifty extended their losing streak to the third consecutive session on Friday amid concerns over
rupee's continuous fall against the US dollar and surging global crude oil prices
Benchmark NSE Nifty50 index was down 133 points at 10,467, while the BSE Sensex was 328 points down at 34,841
Among the 50 stocks in the Nifty index, 18 were trading in the green, while 32 were in the red
Titan Company, Indiabulls Housing Finance, Sun Pharma, Bharti Infratel and IndusInd Bank were among the top gainers in the Nifty
index.
HPCL, BPCL, Indian Oil Corporation, ONGC and GAIL (India) were among the top losers in the Nifty pack of stocks.
